Funding

ClearNote Health

United States · Biotech · Healthtech · AI

Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers

Visit clearnotehealth.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series D$52MMattias Westman — Role not disclosedSandy Weill — Role not disclosedStephen Quake — Role not disclosed

Investors

Mattias WestmanSeries DSandy WeillSeries DStephen QuakeSeries D

Coverage

May 27, 2026ClearNote Health · Series D

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesclearnotehealth.com ↗